26 firms have been given show-cause notices and the Licences of 18 pharma firms cancelled for manufacturing spurious drugs
“Licences of 18 pharma companies have been cancelled for manufacturing spurious and adulterated drugs and for violating GMP (good manufacturing practice)…. Besides, 26 firms have been given show-cause notices and the product permission of three firms have been also cancelled,” the source said.
As part of the special drive, the regulators have identified 203 firms. A majority of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23), sources said.
More such inspections will follow in the coming days, they said. Recently, questions have been raised over the quality of drugs manufactured by India-based companies. In February, the Tamil Nadu-based Global Pharma Healthcare recalled its entire lot of eye drop allegedly linked to vision loss in the US.
Before that, India-made cough syrups were allegedly linked to child deaths in the Gambia and Uzbekistan last year.